These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis. Kart L; Buyukoglan H; Tekin IO; Altin R; Senturk Z; Gulmez I; Demir R; Ozesmi M Mediators Inflamm; 2003 Feb; 12(1):9-14. PubMed ID: 12745543 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of the soluble interleukin-2 receptor level after patients with follicular lymphoma achieve a response to R-CHOP. Umino K; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Minakata D; Nakano H; Yamasaki R; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y Hematology; 2017 Oct; 22(9):521-526. PubMed ID: 28413914 [TBL] [Abstract][Full Text] [Related]
25. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease]. Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100 [TBL] [Abstract][Full Text] [Related]
26. Serum-soluble IL-2 receptor and IL-6 levels in patients with melanoma. Boyano MD; García-Vázquez MD; Gardeazabal J; García de Galdeano A; Smith-Zubiaga I; Cañavate ML; Raton JA; Bilbao I; Díaz-Pérez JL Oncology; 1997; 54(5):400-6. PubMed ID: 9260602 [TBL] [Abstract][Full Text] [Related]
27. Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. Lee YJ; Shin KC; Kang SW; Lee EB; Kim HA; Song YW Clin Exp Rheumatol; 2001; 19(1):69-74. PubMed ID: 11247328 [TBL] [Abstract][Full Text] [Related]
28. Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes: a relationship with disease subtype and clinical outcome. Ogata K; Yokose N; An E; Kamikubo K; Tamura H; Dan K; Sakamaki H; Onozawa Y; Hamaguchi H; Nomura T Br J Haematol; 1996 Apr; 93(1):45-52. PubMed ID: 8611474 [TBL] [Abstract][Full Text] [Related]
30. Circulating soluble interleukin-2 receptor alpha and beta chain in inflammatory bowel disease. Nielsen OH; Ciardelli T; Wu Z; Langholz E; Kirman I Am J Gastroenterol; 1995 Aug; 90(8):1301-6. PubMed ID: 7639234 [TBL] [Abstract][Full Text] [Related]
31. Gamma-interferon and soluble interleukin 2 receptor in tuberculous pleural effusion. Kim YK; Lee SY; Kwon SS; Kim KH; Moon HS; Song JS; Park SH Lung; 2001; 179(3):175-84. PubMed ID: 11891607 [TBL] [Abstract][Full Text] [Related]
32. The levels of plasma interleukin-2 and soluble interleukin-2R in Behçet's disease: a marker of disease activity. Alpsoy E; Cayirli C; Er H; Yilmaz E J Dermatol; 1998 Aug; 25(8):513-6. PubMed ID: 9769596 [TBL] [Abstract][Full Text] [Related]
33. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer. Saito H; Tsujitani S; Ikeguchi M; Maeta M; Kaibara N Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282 [TBL] [Abstract][Full Text] [Related]
34. Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer. De Vita F; Turitto G; di Grazia M; Frattolillo A; Catalano G Tumori; 1998; 84(1):33-8. PubMed ID: 9619711 [TBL] [Abstract][Full Text] [Related]
35. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Aliyazicioglu Y; Mocan H; Gedik Y Am J Hematol; 1998 Feb; 57(2):119-23. PubMed ID: 9462543 [TBL] [Abstract][Full Text] [Related]
36. [Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease]. Peng Q; Wu Q; Chen CH; Hong H; Zhang LY Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):208-10. PubMed ID: 16787593 [TBL] [Abstract][Full Text] [Related]
37. Soluble interleukin-2 receptor (sIL-2R) levels in renal transplantation: comparison between clinical and laboratory analysis. Montagnino G; Tarantino A; Grignani S; Braga M; Ponticelli C Clin Transplant; 1995 Feb; 9(1):25-30. PubMed ID: 7742579 [TBL] [Abstract][Full Text] [Related]
39. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus. Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976 [TBL] [Abstract][Full Text] [Related]
40. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice. Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]